Institutional investors hold a majority ownership of AGN through the 89.43% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2015, these large investors purchased a net $12.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 1.9 Million shares of Allergan
PAULSON & CO., INC. Bought 1.5 Million shares of Allergan
MAVERICK CAPITAL LTD. Bought 1.1 Million shares of Allergan